Pediatrix Medical Group, Inc. · NYSE:MD
Ordan Mark S received 224,372 Pediatrix Medical Group, Inc. shares as an award (Form 4)
Traded Jun 1 to Jun 2, 2026 · Filed Jun 3, 2026
From Jun 1 to Jun 2, 2026, Ordan Mark S (Director, Chief Executive Officer) received 224,372 Pediatrix Medical Group, Inc. shares as an award, leaving 410,884 shares. Filed Jun 3, 2026 (Form 4).
- Awarded
- 224,372 shares
- Holding after
- 410,884 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Award | 127,198 | 430,003 | Direct | |
| Jun 1, 2026 | Common Stock | Shares withheld for tax | 19,119 | US$21.54 | 410,884 | Direct |
| Jun 2, 2026 | Common Stock | Disposition | 97,174 | 313,710 | Direct | |
| Jun 2, 2026 | Common Stock | Award | 97,174 | 410,884 | Direct |
Source
Related
- Pediatrix Medical Group, Inc.
- Ordan Mark S
- Pediatrix Medical Group, Inc. shareholders
- Form 4 · Linynsky Laura A · Sep 14, 2026
- Schedule 13G/A · The Vanguard Group · Sep 3, 2026
- Schedule 13G · Vanguard Capital Management LLC · Sep 3, 2026
- Schedule 13G · Vanguard Portfolio Management LLC · Sep 3, 2026
- Form 4 · Young Sylvia Jean · Aug 18, 2026